Mindfulness-based Stress Reduction for Multiple Sclerosis
Status: | Completed |
---|---|
Conditions: | Neurology, Neurology, Multiple Sclerosis |
Therapuetic Areas: | Neurology, Other |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/17/2018 |
Start Date: | May 2015 |
End Date: | May 30, 2017 |
The primary purpose of this study is to assess the feasibility of mindfulness-based stress
reduction (MBSR) for adults with any type of multiple sclerosis. The secondary objectives are
to: 1) Explore the ability of MBSR to improve perceived stress and quality of life compared
to an education control group; and 2) Explore the durability of the effects of MBSR over one
year.
reduction (MBSR) for adults with any type of multiple sclerosis. The secondary objectives are
to: 1) Explore the ability of MBSR to improve perceived stress and quality of life compared
to an education control group; and 2) Explore the durability of the effects of MBSR over one
year.
Inclusion Criteria:
- Men and women 18 years of age or older
- Definite relapsing remitting, secondary progressive, or primary progressive MS by
revised McDonald criteria;
- Expanded Disability Severity Scale ≤ 8 at baseline;
- Stable on MS disease modifying, anxiolytic, or antidepressant medications for three
months prior to baseline visit;
- Mild to moderate stress defined by a score of ≥ 10 on the Perceived Stress Scale at
screening;
- Ability to read and write in English;
- Willingness to provide informed consent and comply with study activities, including
weekly MBSR sessions and daily practice or weekly Education Control classes.
Exclusion Criteria:
- MBSR or cognitive behavioral therapy training within the last 5 years;
- Current regular meditation or yoga practice (weekly or more often);
- MS exacerbation within 30 days of Baseline Visit;
- Mini-Mental Status Examination (MMSE) score of ≤ 26 at Screening Visit;
- Active suicidal ideation (Beck Depression Inventory) at Screening Visit;
- Reported or medically recorded diagnoses of current serious psychological disorders
other than depression and anxiety;
- Other current life-threatening or severely disabling physical disorders;
- Positive pregnancy urine test at Baseline and women planning pregnancy during the
study period (contraception not required);
- Cancer, other than basal or squamous skin cancers; or
- Inability or unwillingness of individual or legal guardian/representative to give
written informed consent.
We found this trial at
1
site
Portland, Oregon 97201
Principal Investigator: Angela Senders, ND, MCR
Phone: 503-552-1743
Click here to add this to my saved trials